Skip to main content
. 2020 Apr 28;20:315. doi: 10.1186/s12879-020-05028-0

Table 1.

Population characteristics at baseline

MDR-TB treatment outcomes
Total (n = 165) Cured (n = 133) Dead (n = 32)
Age at baseline 33.3 (11.6) 32.2 (10.5) 37.5 (14.7)
Sex (male) 111 (67.3) 97 (72.9) 14 (43.8)
Residence (urban) 122 (73.9) 37 (27.8) 6 (18.8)
BMI 17.5 (2.7) 17.8 (2.6) 16. 0 (2.7)
Initial sputum smear (positive) 145 (87.9) 120 (90.2) 25 (78.1)
Initial sputum culture (positive) 137 (83.0) 113 (88.9) 24 (85.7)
HIV status (positive) 42 (25.6) 27 (20.5) 15 (46.9)
Lung cavities on X-ray (yes) 13 (9.1) 9 (7.7) 4 (15.4)
History of TB treatment (previously treated) 134 (81.2) 114 (85.7) 20 (62.5)
Treatment adherence (yes) 144 (87.3) 128 (96.2) 16 (50.0)
Depression (yes) 8 (4.9) 2 (1.50) 6 (18.8)
Chest pain (yes) 73 (44.2) 54 (40.6) 19 (59.4)
Cough (yes) 156 (94.6) 127 (95.5) 29 (90.6)
Dyspnea (yes) 52 (31.5) 34 (25.6) 18 (56.3)
Nausea (yes) 13 (7.9) 7 (5.3) 6 (18.8)
Vomiting (yes) 17 (10.3) 10 (7.5) 7 (21.9)
Hemoglobin count 10.7 (2.2) 10.8 (2.1) 10.0 (2.6)
Platelet count 388.0 (159.9) 396.1 (152.4) 353.8 (187.1)
Lymphocyte count 1.9 (1.4) 1.8 (0.9) 2.0 (2.6)
Neutrophil count 5.0 (2.6) 5.0 (2.6) 5.5 (2.7)
Creatinine 77.7 (19.6) 76.8 (19.5) 81.3 (19.7)
SGOT 29.6 (5.4) 29.2 (3.8) 31.2 (9.3)
SGPT 32.2 (5.0) 32.2 (4.2) 32.3 (7.6)

Data are expressed as n number (%) for categorical variable, and mean (SD); SD standard deviation for continuous variable